Formulation of guidelines for treatment
Bishop, M.C.
Lancet 347(8997): 331
1996
ISSN/ISBN: 0140-6736 PMID: 8569390 DOI: 10.1016/s0140-6736(96)90509-7Document Number: 295350
Document emailed within 0-6 h
Related Documents
Burris, H.; Parkhurst, J.; Adu-Sarkodie, Y.; Mayaud, P. 2011: Getting research into policy - Herpes simplex virus type-2 (HSV-2) treatment and HIV infection: international guidelines formulation and the case of Ghana Health Research Policy and Systems 9 Suppl. 1: S5Levine, W.C.; Berg, A.O.; Johnson, R.E.; Rolfs, R.T.; Stone, K.M.; Hook, E.W.; Handsfield, H.H.; Holmes, K.K.; Islam, M.Q.; Piot, P. 1994: Development of sexually transmitted diseases treatment guidelines, 1993. New methods, recommendations, and research priorities. STD Treatment Guidelines Project Team and Consultants Sexually Transmitted Diseases 21(2 Suppl): S96-101
Levine, W.C.; Berg, A.O.; Johnson, R.E.; Rolfs, R.T.; Stone, K.M.; Hook, E.W.; Handsfield, H.H.; Holmes, K.K.; Islam, M.Q.; Piot, P. 1994: Development of sexually transmitted diseases treatment guidelines, 1993. New methods, recommendations, and research priorities. STD Treatment Guidelines Project Team and Consultants Sexually Transmitted Diseases 21(2 Suppl): S96-101
Xu, H. 2010: Evidence-based guidelines for diagnosis and treatment of common renal diseases in children (for trial) (VII): guidelines for the diagnosis and treatment of urinary tract infection Zhonghua Er Ke Za Zhi 48(11): 814-816
Gazzard, B.; Moyle, G. 1998: 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing Committee Lancet 352(9124): 314-316
2002: Tobramycin for nebulisation: new formulation. A high price for a small improvement in formulation Prescrire International 11(62): 177-178
2003: Sublingual selegiline: new formulation. New formulation: new risk of oral adverse effects Prescrire International 12(67): 179
Wang, Y.J.; Leesman, G.D.; Lipstein, M.E.; Basch, H.I.; Monkhouse, D.C. 1984: Optimization of autoclave cycles and selection of formulation for parenteral products, Part III: Effect of formulation variables on sporicidal kinetics Journal of parenteral science and technology: a publication of the Parenteral Drug Association 38(2): 78-82
Huang, X.J. 2017: Evaluate the role of the guidelines from the development of "Chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers" in China Zhonghua Nei Ke Za Zhi 56(6): 393-394
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47
2003: Paracetamol for injection: new formulation. New formulation: why so widely used? Prescrire International 12(67): 178
Ewen, K.; Lauber, I. 2004: Which points deserve special attention in the new guidelines on X-ray use (testing guidelines for experts and quality assurance guidelines)? Der Radiologe 44(12): 1197-1205
Vens-Cappell, B.; Hilgenstock, C.; Gellert, M.; Kühle, K.; Reifferscheid, I.; Winckler, P.; Bührens, K.G. 1993: Comparison of the pharmacokinetics of a quick-release bezafibrate formulation with a sustained-release formulation. 1. Single-dose administration Arzneimittel-Forschung 43(3): 346-350
2003: Revised U.S. adult and adolescent antiretroviral treatment guidelines; also revised pediatric guidelines AIDS treatment news 2003(396): 4-5
Jehl, F.; Klossek, J.M.; Peynegre, R.; Serrano, E.; Castillo, L.; Bobin, S.; Desprez, D.; Renault, C.; Neel, V.; Rouffiac, E.; Borie, C. 2002: Sinusal penetration of amoxicillin-clavulanic acid. Formulation 1 g./125 mg., twice daily versus formulation 500 mg./125 mg., three times daily Presse Medicale 31(34): 1596-1603
Ward, J.E.; Grieco, V. 1996: Why we need guidelines for guidelines: a study of the quality of clinical practice guidelines in Australia Medical Journal of Australia 165(10): 574-576
Krieger, J.N. 1995: New Sexually Transmitted Diseases Treatment Guidelines* *A free copy of the Sexually Transmitted Diseases Treatment Guidelines (Hhs Publication No. Cdc 93-8017) may be obtained from the Superintendent of Documents, U. S. Government Printing Office, Washington, D. C. 20402; telephone (202) 783-3238 or Centers for Disease Control and Prevention, Atlanta, Georgia 30333; telephone (404) 332-4555 The Journal of Urology 154(1): 209-213
Krieger, J.N. 1995: New Sexually Transmitted Diseases Treatment Guidelines* *A free copy of the Sexually Transmitted Diseases Treatment Guidelines (Hhs Publication No. Cdc 93-8017) may be obtained from the Superintendent of Documents, U. S. Government Printing Office, Washington, D. C. 20402; telephone (202) 783-3238 or Centers for Disease Control and Prevention, Atlanta, Georgia 30333; telephone (404) 332-4555 The Journal of Urology 154(1): 209-213
Guevara, I.L.; Werlinger, K.D.; Pandya, A.G. 2010: Tolerability and efficacy of a novel formulation in the treatment of melasma Journal of Drugs in Dermatology: Jdd 9(3): 215-218
Gold, M.H.; Kircik, L.H.; Bucay, V.W.; Kiripolsky, M.G.; Biron, J.A. 2013: Treatment of facial photodamage using a novel retinol formulation Journal of Drugs in Dermatology: Jdd 12(5): 533-540